Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort.
Kawazoe A, Yamamoto N, Sugimoto N, Kawakami H, Oshima T, Yamaguchi K, Hino K, Hirao M, Kurokawa Y, Kawakami T, Tsuda M, Hara H, Kaname S, Matsuoka D, Otake Y, Yasuda K, Takase T, Takashima S, Semba T, Muro K. Kawazoe A, et al. Among authors: otake y. Clin Cancer Res. 2024 Apr 1;30(7):1264-1272. doi: 10.1158/1078-0432.CCR-23-1768. Clin Cancer Res. 2024. PMID: 38295160 Free PMC article. Clinical Trial.
Phase Ib/II Study of a Liposomal Formulation of Eribulin (E7389-LF) plus Nivolumab in Patients with Advanced Solid Tumors: Results from Phase Ib.
Ida H, Shimizu T, Nishino M, Nakamura Y, Yazaki S, Katsuya Y, Sato J, Koyama T, Iwasa S, Sudo K, Kondo S, Yonemori K, Shitara K, Shiono S, Matsuoka D, Yasuda K, Otake Y, Suzuki T, Takase T, Takashima S, Yamaguchi K, Semba T, Yamamoto N. Ida H, et al. Among authors: otake y. Cancer Res Commun. 2023 Jul 10;3(7):1189-1199. doi: 10.1158/2767-9764.CRC-22-0401. eCollection 2023 Jul. Cancer Res Commun. 2023. PMID: 37435605 Free PMC article. Clinical Trial.
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort.
Nishio M, Murakami S, Kawakami H, Okishio K, Tamiya M, Kobayashi H, Fujimoto D, Sugawara S, Kozuki T, Oya Y, Izumi H, Shiroyama T, Satouchi M, Yamamoto N, Kaname S, Matsuoka D, Otake Y, Takase T, Semba T, Azuma K. Nishio M, et al. Among authors: otake y. Cancer Res Commun. 2024 Jan 29;4(1):226-235. doi: 10.1158/2767-9764.CRC-23-0313. Cancer Res Commun. 2024. PMID: 38181055 Free PMC article. Clinical Trial.
Prevalence and Risk Factors of Constipation Symptoms among Patients Undergoing Colonoscopy: A Single-Center Cross-Sectional Study.
Komori S, Akiyama J, Tatsuno N, Yamada E, Izumi A, Hamada M, Seto K, Nishiie Y, Suzuki K, Hisada Y, Otake Y, Yanai Y, Okubo H, Watanabe K, Akazawa N, Yamamoto N, Tanaka Y, Yanase M, Saito A, Yamada K, Yokoi C, Nagahara A. Komori S, et al. Among authors: otake y. Digestion. 2024 May 16. doi: 10.1159/000539366. Online ahead of print. Digestion. 2024. PMID: 38754395
Magnetic resonance imaging features of complete androgen insensitivity syndrome in comparison to Mayer-Rokitansky-Küster-Hauser syndrome.
Nakamata A, Matsuki M, Otake Y, Himoto Y, Kaneko Y, Nakaya M, Sudo N, Kikuchi T, Watanabe Y, Kobayashi R, Masuoka S, Kunitomo N, Fujii H, Hamamoto K, Mori H. Nakamata A, et al. Among authors: otake y. Abdom Radiol (NY). 2024 Apr 11. doi: 10.1007/s00261-024-04282-z. Online ahead of print. Abdom Radiol (NY). 2024. PMID: 38602521
392 results